A 26-week randomized controlled trial of semaglutide once daily versus liraglutide and placebo in patients with type 2 diabetes suboptimally controlled on diet and exercise with or without metformin

Ildiko Lingvay, Cyrus V. Desouza, Katarina S. Lalic, Ludger Rose, Thomas Hansen, Jeppe Zacho, Thomas R. Pieber*

*Corresponding author af dette arbejde
45 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'A 26-week randomized controlled trial of semaglutide once daily versus liraglutide and placebo in patients with type 2 diabetes suboptimally controlled on diet and exercise with or without metformin'. Sammen danner de et unikt fingeraftryk.

Medicin og biovidenskab